ACOR - Acorda Therapeutics Non-GAAP EPS of -$0.67 revenue of $36.07M beats by $5.06M March, 09 2022 04:03 PM Acorda Therapeutics Inc. Acorda Therapeutics press release (NASDAQ:ACOR): Q4 Non-GAAP EPS of -$0.67. Revenue of $36.07M (-5.5% Y/Y) beats by $5.06M. For further details see: Acorda Therapeutics Non-GAAP EPS of -$0.67, revenue of $36.07M beats by $5.06M